The new Laboratory of Biohybrid Technologies was founded at the beginning of 2018 at the Institute of Chemistry of St. Petersburg State University. This became possible because of the Megagrant from the Government of the Russian Federation, which was gained by the group of Prof. Tatiana Tennikova together with one of the one of the world's leading pharmacists from University of Helsinki and University of Eastern Finland in Kuopio — Prof. Arto Urtti. Now he is the Head of the new Laboratory at the Institute of Chemistry.
The research at the Laboratory is aimed to develop the methods of preparation and application of biohybrids for the targeted delivery of a wide range of medicinal compounds, including steroids, peptides/proteins, short interfering RNA, small organic molecules and organometallic complexes (luminescent compounds of the new generation). The testing of new technologies is carried out with application of ocular diseases models with the possibility of further transfer of obtained results to other biological systems. Biohybrids could be defined as “living containers” for drug delivery. Chemically modified living cells (bacteria, mammalian cells) or isolated cell membranes filled with drug “cargo” could be attributed to such systems.